
Vagifem, Libido, and Rediscovering Your Sex Drive
Discover how Vagifem addresses vaginal atrophy to help restore comfort and libido during menopause.
Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993

For visual reference only; actual product may vary
US Name:
Lucentis
Alternative Names:
Lucentis
Active Ingredients:
Ranibizumab
Brand Manufacturer:
Manufacturer Location:
Click here to view Product Insert
Click here to view Product Insert
Click here to view Product Insert

For visual reference only; actual product may vary
Lucentis (ranibizumab) is a specialized injectable medication for treating serious eye conditions. It is administered by an eye doctor to manage wet age-related macular degeneration (AMD), diabetic eye disease, and retinal vein blockages. This advanced treatment helps preserve vision by targeting abnormal blood vessel growth in the eye.
| Lucentis Brand | 120mg/mL 1 Vial |
-
|
Our price: $825.00 |
|
| Lucentis Brand | 0.5mg/0.05ml 1 Pre-Filled Syringe |
-
|
Our price: $715.00 |
Lucentis is a prescription medication designed to treat several serious eye conditions. It is a type of medicine known as an anti-vascular endothelial growth factor (anti-VEGF) therapy. Lucentis is administered directly into the eye through a very fine needle. This procedure, called an intravitreal injection, is performed by an ophthalmologist (a specialized eye doctor). The medication is primarily used to manage conditions that affect the retina, the light-sensitive tissue at the back of the eye. Its purpose is to prevent further vision loss and, in some cases, to improve vision. This treatment targets the underlying causes of abnormal blood vessel growth and leakage in the eye.
Lucentis works by blocking a specific protein in your body called vascular endothelial growth factor A (VEGF-A). This protein plays a key role in the formation of new blood vessels. In certain eye diseases, excessive amounts of VEGF-A can cause abnormal, weak, and leaky blood vessels to grow in the retina. These new vessels can leak fluid and blood. This leakage leads to swelling and damage to the macula, the part of the retina responsible for sharp, central vision. By inhibiting VEGF-A, Lucentis helps to reduce the growth of these harmful blood vessels. This action decreases swelling, stops leakage, and helps to slow down vision loss, preserving the patient’s sight.
Lucentis is for patients diagnosed with specific retinal conditions that can lead to significant vision impairment. This treatment is often prescribed for adults with wet age-related macular degeneration (AMD). It is also used for individuals who have vision problems caused by diabetic macular edema (DME), a complication of diabetes. Other patients who may benefit include those with macular edema resulting from a blockage in the veins of the retina (retinal vein occlusion, or RVO). It can also treat myopic choroidal neovascularization, a complication of severe nearsightedness. Finally, it is used in premature infants for a condition called retinopathy of prematurity.
Lucentis dosage and administration depend on the condition being treated and the patient’s response to therapy. The medication is given as an injection into the vitreous humor (the gel-like substance that fills the eye) by a retinal specialist. The procedure is done in a doctor’s office under sterile conditions. Before the injection, the doctor will clean the eye and apply a strong anesthetic to numb it and minimize discomfort. Patients typically receive injections once a month to start. Over time, if the condition stabilizes, the interval between treatments may be extended. The exact schedule is determined by the ophthalmologist based on regular eye exams and imaging tests.
Lucentis may cause side effects, most of which are related to the injection itself rather than the drug. It is important to discuss these with your doctor. Common side effects are generally mild and temporary.
More serious side effects are rare but require immediate medical attention. These can include signs of a severe eye infection (endophthalmitis), retinal detachment, or a significant increase in eye pressure. Systemic risks like blood clots, heart attack, or stroke have also been reported, although they are uncommon.
IsraelPharm is a trusted source for essential medications like Lucentis. We are committed to providing safe, affordable access to prescription drugs. Our products are sourced from licensed, regulated pharmacies, ensuring you receive genuine medication. Because this product requires careful handling, we provide cold shipping to maintain its integrity from the pharmacy to your door. Our knowledgeable customer service team is here to assist you with your order. By choosing IsraelPharm, you can save on your medication costs without compromising on quality or safety, helping you manage your health affordably.
Common side effects associated with the injection procedure include:
Serious but rare adverse reactions can occur:
Contact your doctor immediately if you experience severe eye pain, vision changes, or signs of infection.
Lucentis (ranibizumab) is indicated for the treatment of:
Lucentis begins working to block harmful protein growth soon after the first injection. Patients may notice an improvement or stabilization of their vision within the first week to a month. Individual results can vary depending on the specific eye condition and its severity. Regular follow-up with your ophthalmologist is key to tracking progress.
Lucentis injections are administered after the eye is numbed with anesthetic drops, so the injection itself is usually not painful. Patients might feel a brief sensation of pressure. Some discomfort, scratchiness, or mild pain can occur after the anesthetic wears off, but this is typically mild and temporary.
Lucentis may cause some common side effects related to the injection. These can include seeing floaters or specks in your vision, eye redness, mild eye pain, or a feeling of something in the eye. Increased eye pressure is also common but it is monitored by your doctor before and after the procedure.
Lucentis is administered after your eye is dilated, which will cause blurred vision and light sensitivity. It is not safe to drive yourself home after the procedure. You should arrange for someone to drive you home and plan to rest your eyes for the remainder of the day to recover.
Lucentis treatment frequency depends on your specific condition and your doctor's assessment of your progress. Initially, injections are often given once a month. As your condition stabilizes, the time between injections may be extended based on retinal scans. Your ophthalmologist will create a personalized treatment schedule for you.
Lucentis can cause mild discomfort, but severe, worsening eye pain or a significant decrease in vision could be signs of a serious problem like an infection. You should contact your retinal specialist immediately if you experience these symptoms several days after your injection, as prompt treatment for complications is critical.
Lucentis can help improve vision in many patients with wet AMD, but its primary goal is to stop further vision loss. While some people regain lost sight, the treatment is not a guaranteed cure to reverse all damage. The main objective is to stabilize the condition and preserve existing vision.
Lucentis requires no special preparation from your side. Be sure to inform your doctor of all medications you are taking, especially any blood thinners. You should also arrange for transportation, as your eyes will be dilated for the procedure, making it unsafe for you to drive home afterward.
Lucentis belongs to a class of drugs called anti-VEGF therapies. Other drugs in this class, such as Avastin (bevacizumab) and Eylea (aflibercept), are also used to treat similar retinal conditions. Your ophthalmologist will determine the most appropriate treatment option based on your specific medical case and needs.
Lucentis is administered locally into the eye, so systemic drug interactions are considered rare. However, it is crucial to tell your doctor about all medications you take, especially blood thinners like warfarin or aspirin. These may increase the risk of bleeding at the injection site in the eye.
Lucentis and Avastin are both anti-VEGF drugs that work in a similar way to treat retinal conditions. Lucentis (ranibizumab) was specifically designed for eye injections. Avastin (bevacizumab) was developed for cancer treatment but is often used off-label for the eye, primarily due to its lower cost. The choice depends on clinical factors.
Lucentis injections sometimes involve a small gas bubble being placed in the eye to help the retina. If you have a gas bubble, flying or scuba diving is very dangerous. Pressure changes can cause the bubble to expand, leading to a severe increase in eye pressure. Always ask your doctor if it is safe for you to fly.
Lucentis must be stored in a refrigerator at a controlled temperature between 2°C and 8°C (36°F and 46°F). It should not be frozen and must be protected from light. This is why it requires special cold shipping and careful handling to ensure it remains effective and safe for administration.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.

Discover how Vagifem addresses vaginal atrophy to help restore comfort and libido during menopause.

Learn how biologic medications like Stelara and Prolia treat chronic conditions by targeting specific parts of the immune system and bone cells.

For so many women, their own health takes a back seat – not because they ignore it, but rather because life is loud. Work, family, caregiving, aging parents, hormones, sleep, stress. Life is like a


